UNSPSC 51131822: Coagulation factor xiv or protein c

This classification denotes an antifibrinolytic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JGH8MYC891. European Medicines Agency schedules Coagulation factor xiv in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12567MIG.

UNSPSC 51131822 Coagulation factor XIV or protein C is a Commodity code that nominally designates anticoagulant blood products, yet the only recent state and local procurement activity tagged to this code shows no alignment with that scope. Sourcewell, a State of Minnesota local government unit and service cooperative, posted RFP #061626 on May 12, 2026 for Law Enforcement Equipment — a commodity family entirely unrelated to coagulation factors or blood products. The mismatch suggests either a classification error in the opportunity posting or that this code does not reflect active state and local procurement in its intended product category. No other recent opportunities appear in the source.

The single opportunity named — Sourcewell's law enforcement equipment RFP with a June 16, 2026 response deadline — operates as a cooperative purchasing vehicle open to thousands of governmental agencies, K-12 school districts, higher education institutions, tribal governments, and public entities across the United States and Canada, with initial participation from multiple Washington state counties (Franklin, Grant, Grays Harbor, Chelan, and Yakima). Vendors must respond through the Sourcewell Procurement Portal by 3:30 p.m. Central Time. Because this opportunity is classified under the anticoagulant code but buys law enforcement equipment, the code shows little relevant recent activity in its stated domain. Firms pursuing actual blood-product procurement under this Commodity code should expect activity through health departments, hospital systems, or clinical-procurement channels rather than through Sourcewell's cooperative or the jurisdictions named here.